Latest Earnings Results: Q2 '26
Estimated EPS
$0.10
Reported EPS
$0.15
Surprise
+42.86%
Estimated Rev
$36.35M
Reported Rev
$36.93M
Surprise
+1.6%
InfuSystem reaffirms 2026 full-year guidance, estimating pro-forma net revenue growth between 6% to 8% and continuing to forecast an Adjusted EBITDA margin in the mid to low 20% range.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.13 | -- | -- | N/A |
Q2 '26 | $0.10 | $0.15 | 42.86% | BEAT |
Q1 '26 | $0.03 | $0.05 | 47.06% | BEAT |
Q4 '25 | $0.06 | $0.10 | 53.85% | BEAT |
Q3 '25 | $0.08 | $0.11 | 37.50% | BEAT |